Skip to main content
Erschienen in: Supportive Care in Cancer 9/2015

01.09.2015 | Original Article

Survivorship care plans and time since diagnosis: factors that contribute to who breast cancer survivors see for the majority of their care

verfasst von: Kara P. Wiseman, Diane L. Bishop, Qin Shen, Resa M. Jones

Erschienen in: Supportive Care in Cancer | Ausgabe 9/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The study purpose is to describe who breast cancer survivors see for their care by years since diagnosis and determine the association between time since diagnosis and the type of clinician providing the majority of care, taking into account receipt of follow-up care instructions.

Methods

The 2010 Behavioral Risk Factor Surveillance System was used to identify a sample (N = 1024) of women with a self-reported history of breast cancer. Descriptive characteristics were calculated and stratified by years since diagnosis. Multivariate logistic regression adjusting for age, income, and receiving follow-up care instructions was performed to evaluate the association between years since diagnosis and clinician providing the majority of care.

Results

The type of clinician reported most frequently was a primary care provider. Women 0–1 year since diagnosis had the highest proportion reporting a cancer-related clinician for their care. After adjustment, women 0–1, 2–3, and 4–5 years since diagnosis were respectively 2.1, 2.6, and 1.7 times more likely to have a cancer-related clinician providing the majority of care compared to women 6+ years since diagnosis (respective 95 % confidence intervals (CIs) 1.0–4.3; 1.4–4.6; 0.9–3.1).

Conclusions

Breast cancer survivors receive the majority of their care from primary care providers, and years since diagnosis has a significant impact on who survivors see for their care. Breast cancer survivors have nationally recommended follow-up guidelines; however, the type of clinician that should provide care is not specified. Information regarding who provides the majority of care can be used for future planning and policy development.
Literatur
1.
Zurück zum Zitat American Cancer Society (2014) Cancer facts & figures 2014. American Cancer Society, Atlanta, GA American Cancer Society (2014) Cancer facts & figures 2014. American Cancer Society, Atlanta, GA
2.
Zurück zum Zitat Hewitt M, Greenfield S, Stovall E (eds) (2005) From cancer patient to cancer survivor: lost in transition. The National Academies Press, Washington, DC Hewitt M, Greenfield S, Stovall E (eds) (2005) From cancer patient to cancer survivor: lost in transition. The National Academies Press, Washington, DC
3.
Zurück zum Zitat American Cancer Society (2013) Breast cancer facts & figures 2013-2014. American Cancer Society, Atlanta, GA American Cancer Society (2013) Breast cancer facts & figures 2013-2014. American Cancer Society, Atlanta, GA
4.
Zurück zum Zitat Centers for Disease Control and Prevention (CDC) (2011) Cancer survivors—United States, 2007. MMWR Morb Mortal Wkly Rep 60:269–272 Centers for Disease Control and Prevention (CDC) (2011) Cancer survivors—United States, 2007. MMWR Morb Mortal Wkly Rep 60:269–272
5.
Zurück zum Zitat National Comprehensive Care Network (2012) NCCN clinical practice guidelines in oncology (NCCN guidelines)® breast cancer. Version 1.2012 National Comprehensive Care Network (2012) NCCN clinical practice guidelines in oncology (NCCN guidelines)® breast cancer. Version 1.2012
6.
Zurück zum Zitat Khatcheressian JL, Wolff AC, Smith TJ et al (2006) American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol 24:5091–5097PubMedCrossRef Khatcheressian JL, Wolff AC, Smith TJ et al (2006) American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol 24:5091–5097PubMedCrossRef
7.
Zurück zum Zitat Friese CR, Martinez KA, Abrahamse P et al (2014) Providers of follow-up care in a population-based sample of breast cancer survivors. Breast Cancer Res Treat 144:179–184PubMedCentralPubMedCrossRef Friese CR, Martinez KA, Abrahamse P et al (2014) Providers of follow-up care in a population-based sample of breast cancer survivors. Breast Cancer Res Treat 144:179–184PubMedCentralPubMedCrossRef
8.
Zurück zum Zitat Grunfeld E, Levine MN, Julian JA et al (2006) Randomized trial of long-term follow-up for early-stage breast cancer: a comparison of family physician versus specialist care. J Clin Oncol 24:848–855PubMedCrossRef Grunfeld E, Levine MN, Julian JA et al (2006) Randomized trial of long-term follow-up for early-stage breast cancer: a comparison of family physician versus specialist care. J Clin Oncol 24:848–855PubMedCrossRef
9.
Zurück zum Zitat Grunfeld E, Earle CC (2010) The interface between primary and oncology specialty care: treatment through survivorship. J Natl Cancer Inst Monogr 2010:25–30PubMedCentralPubMedCrossRef Grunfeld E, Earle CC (2010) The interface between primary and oncology specialty care: treatment through survivorship. J Natl Cancer Inst Monogr 2010:25–30PubMedCentralPubMedCrossRef
10.
Zurück zum Zitat Lewis RA, Neal RD, Williams NH et al (2009) Follow-up of cancer in primary care versus secondary care: systematic review. Br J Gen Pract 59:e234–e247PubMedCentralPubMedCrossRef Lewis RA, Neal RD, Williams NH et al (2009) Follow-up of cancer in primary care versus secondary care: systematic review. Br J Gen Pract 59:e234–e247PubMedCentralPubMedCrossRef
11.
Zurück zum Zitat Friedberg MW, Hussey PS, Schneider EC (2010) Primary care: a critical review of the evidence on quality and costs of health care. Health Aff (Millwood) 29:766–772CrossRef Friedberg MW, Hussey PS, Schneider EC (2010) Primary care: a critical review of the evidence on quality and costs of health care. Health Aff (Millwood) 29:766–772CrossRef
13.
Zurück zum Zitat Grunfeld E, Hodgson DC, Del Giudice ME, Moineddin R (2010) Population-based longitudinal study of follow-up care for breast cancer survivors. J Oncol Pract 6:174–181PubMedCentralPubMedCrossRef Grunfeld E, Hodgson DC, Del Giudice ME, Moineddin R (2010) Population-based longitudinal study of follow-up care for breast cancer survivors. J Oncol Pract 6:174–181PubMedCentralPubMedCrossRef
14.
Zurück zum Zitat Keating NL, Landrum MB, Guadagnoli E, Winer EP, Ayanian JZ (2007) Surveillance testing among survivors of early-stage breast cancer. J Clin Oncol 25:1074–1081PubMedCrossRef Keating NL, Landrum MB, Guadagnoli E, Winer EP, Ayanian JZ (2007) Surveillance testing among survivors of early-stage breast cancer. J Clin Oncol 25:1074–1081PubMedCrossRef
15.
Zurück zum Zitat Worster A, Wood ML, McWhinney IR, Bass MJ (1995) Who provides follow-up care for patients with early breast cancer? Can Fam Physician 41:1314–1320PubMedCentralPubMed Worster A, Wood ML, McWhinney IR, Bass MJ (1995) Who provides follow-up care for patients with early breast cancer? Can Fam Physician 41:1314–1320PubMedCentralPubMed
16.
Zurück zum Zitat Mandelblatt JS, Lawrence WF, Cullen J et al (2006) Patterns of care in early-stage breast cancer survivors in the first year after cessation of active treatment. J Clin Oncol 24:77–84PubMedCrossRef Mandelblatt JS, Lawrence WF, Cullen J et al (2006) Patterns of care in early-stage breast cancer survivors in the first year after cessation of active treatment. J Clin Oncol 24:77–84PubMedCrossRef
17.
Zurück zum Zitat Pollack LA, Adamache W, Ryerson AB, Eheman CR, Richardson LC (2009) Care of long-term cancer survivors: physicians seen by Medicare enrollees surviving longer than 5 years. Cancer 115:5284–5295PubMedCrossRef Pollack LA, Adamache W, Ryerson AB, Eheman CR, Richardson LC (2009) Care of long-term cancer survivors: physicians seen by Medicare enrollees surviving longer than 5 years. Cancer 115:5284–5295PubMedCrossRef
18.
Zurück zum Zitat Chubak J, Aiello Bowles EJ, Tuzzio L et al (2014) Perspectives of cancer survivors on the role of different healthcare providers in an integrated delivery system. J Cancer Surviv 8:229–238PubMedCentralPubMedCrossRef Chubak J, Aiello Bowles EJ, Tuzzio L et al (2014) Perspectives of cancer survivors on the role of different healthcare providers in an integrated delivery system. J Cancer Surviv 8:229–238PubMedCentralPubMedCrossRef
19.
Zurück zum Zitat Jabson JM, Bowen DJ (2013) Cancer treatment summaries and follow-up care instructions: which cancer survivors receive them? Cancer Causes Control 24:861–871PubMedCrossRef Jabson JM, Bowen DJ (2013) Cancer treatment summaries and follow-up care instructions: which cancer survivors receive them? Cancer Causes Control 24:861–871PubMedCrossRef
23.
Zurück zum Zitat Azrad M, Demark-Wahnefried W (2014) The association between adiposity and breast cancer recurrence and survival: a review of the recent literature. Curr Nutr Rep 3:9–15PubMedCentralPubMedCrossRef Azrad M, Demark-Wahnefried W (2014) The association between adiposity and breast cancer recurrence and survival: a review of the recent literature. Curr Nutr Rep 3:9–15PubMedCentralPubMedCrossRef
24.
Zurück zum Zitat American Cancer Society (2012) Breast cancer facts & figures 2011–2012. American Cancer Society, Atlanta, GA American Cancer Society (2012) Breast cancer facts & figures 2011–2012. American Cancer Society, Atlanta, GA
25.
Zurück zum Zitat Roorda C, de Bock GH, Scholing C, van der Meer K et al (2014) Patients’ preferences for post-treatment breast cancer follow-up in primary care vs. secondary care: a qualitative study. Health Expect. doi:10.1111/hex.12189 PubMed Roorda C, de Bock GH, Scholing C, van der Meer K et al (2014) Patients’ preferences for post-treatment breast cancer follow-up in primary care vs. secondary care: a qualitative study. Health Expect. doi:10.​1111/​hex.​12189 PubMed
26.
Zurück zum Zitat Saphner T, Tormey DC, Gray R (1996) Annual hazard rates of recurrence for breast cancer after primary therapy. J Clin Oncol 14:2738–2746PubMed Saphner T, Tormey DC, Gray R (1996) Annual hazard rates of recurrence for breast cancer after primary therapy. J Clin Oncol 14:2738–2746PubMed
27.
Zurück zum Zitat Potosky AL, Han PK, Rowland J et al (2011) Differences between primary care physicians’ and oncologists’ knowledge, attitudes and practices regarding the care of cancer survivors. J Gen Intern Med 26:1403–1410PubMedCentralPubMedCrossRef Potosky AL, Han PK, Rowland J et al (2011) Differences between primary care physicians’ and oncologists’ knowledge, attitudes and practices regarding the care of cancer survivors. J Gen Intern Med 26:1403–1410PubMedCentralPubMedCrossRef
28.
Zurück zum Zitat Sabatino SA, Thompson TD, Smith JL et al (2013) Receipt of cancer treatment summaries and follow-up instructions among adult cancer survivors: results from a national survey. J Cancer Surviv 7:32–43PubMedCrossRef Sabatino SA, Thompson TD, Smith JL et al (2013) Receipt of cancer treatment summaries and follow-up instructions among adult cancer survivors: results from a national survey. J Cancer Surviv 7:32–43PubMedCrossRef
29.
Zurück zum Zitat Oeffinger KC, McCabe MS (2006) Models for delivering survivorship care. J Clin Oncol 24:5117–5124PubMedCrossRef Oeffinger KC, McCabe MS (2006) Models for delivering survivorship care. J Clin Oncol 24:5117–5124PubMedCrossRef
30.
Zurück zum Zitat Oeffinger KC, Argenbright KE, Levitt GA et al (2014) Models of cancer survivorship health care: moving forward. Am Soc Clin Oncol Educ Book: 205–213 Oeffinger KC, Argenbright KE, Levitt GA et al (2014) Models of cancer survivorship health care: moving forward. Am Soc Clin Oncol Educ Book: 205–213
Metadaten
Titel
Survivorship care plans and time since diagnosis: factors that contribute to who breast cancer survivors see for the majority of their care
verfasst von
Kara P. Wiseman
Diane L. Bishop
Qin Shen
Resa M. Jones
Publikationsdatum
01.09.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 9/2015
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-015-2629-5

Weitere Artikel der Ausgabe 9/2015

Supportive Care in Cancer 9/2015 Zur Ausgabe

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.